Compositions and methods of delivery of pharmacological agents

Details Compositions and methods of delivery of pharmacological agents Compositions and methods of delivery of pharmacological agents

2006-10-26

2010-10-26

Monshipouri, Maryam (Department: 1656)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C977S779000, C977S906000

Reexamination Certificate

active

07820788

ABSTRACT:
The present invention relates to a pharmaceutical composition comprising a pharmaceutical agent and a pharmaceutically acceptable carrier, which carrier comprises a protein, for example, human serum albumin and/or deferoxamine. The human serum albumin is present in an amount effective to reduce one or more side effects associated with administration of the pharmaceutical composition. The invention also provides methods for reducing one or more side effects of administration of the pharmaceutical composition, methods for inhibiting microbial growth and oxidation in the pharmaceutical composition, and methods for enhancing transport and binding of a pharmaceutical agent to a cell.

REFERENCES:
patent: 4425319 (1984-01-01), Yokoyama et al.
patent: 4645660 (1987-02-01), Takahashi et al.
patent: 5272171 (1993-12-01), Ueda et al.
patent: 5362478 (1994-11-01), Desai et al.
patent: 5399363 (1995-03-01), Liversidge et al.
patent: 5439686 (1995-08-01), Desai et al.
patent: 5498421 (1996-03-01), Grinstaff et al.
patent: 5505932 (1996-04-01), Grinstaff et al.
patent: 5508021 (1996-04-01), Grinstaff et al.
patent: 5512268 (1996-04-01), Grinstaff et al.
patent: 5560933 (1996-10-01), Soon-Shiong et al.
patent: 5616330 (1997-04-01), Kaufman et al.
patent: 5626862 (1997-05-01), Brem et al.
patent: 5635207 (1997-06-01), Grinstaff et al.
patent: 5639473 (1997-06-01), Grinstaff et al.
patent: 5650156 (1997-07-01), Grinstaff et al.
patent: 5651986 (1997-07-01), Brem et al.
patent: 5665382 (1997-09-01), Grinstaff et al.
patent: 5665383 (1997-09-01), Grinstaff et al.
patent: 5681846 (1997-10-01), Trissel
patent: 5714520 (1998-02-01), Jones et al.
patent: 5716981 (1998-02-01), Hunter et al.
patent: 5731355 (1998-03-01), Jones et al.
patent: 5731356 (1998-03-01), Jones et al.
patent: 5886026 (1999-03-01), Hunter et al.
patent: 5916596 (1999-06-01), Desai et al.
patent: 5945033 (1999-08-01), Yen
patent: 5977163 (1999-11-01), Li et al.
patent: 5990153 (1999-11-01), Wood et al.
patent: 5994341 (1999-11-01), Hunter et al.
patent: 5997904 (1999-12-01), Magdassi et al.
patent: 6028108 (2000-02-01), George
patent: 6096331 (2000-08-01), Desai et al.
patent: 6100302 (2000-08-01), Pejaver et al.
patent: 6120805 (2000-09-01), Spenlehauer et al.
patent: 6143276 (2000-11-01), Unger
patent: 6147122 (2000-11-01), Mirejovsky et al.
patent: 6150423 (2000-11-01), Carpenter
patent: 6177477 (2001-01-01), George et al.
patent: 6197051 (2001-03-01), Zhong
patent: 6197349 (2001-03-01), Westesen et al.
patent: 6204054 (2001-03-01), Sutton et al.
patent: 6306993 (2001-10-01), Rothbard et al.
patent: 6310039 (2001-10-01), Kratz
patent: 6326406 (2001-12-01), De Tommaso
patent: 6362234 (2002-03-01), Hendler
patent: 6399087 (2002-06-01), Zhang et al.
patent: 6441025 (2002-08-01), Li et al.
patent: 6458373 (2002-10-01), Lambert et al.
patent: 6469069 (2002-10-01), Mirejovsky et al.
patent: 6506405 (2003-01-01), Desai et al.
patent: 6528067 (2003-03-01), Magdassi et al.
patent: 6537579 (2003-03-01), Desai et al.
patent: 6565842 (2003-05-01), Sojomihardo et al.
patent: 6652884 (2003-11-01), Falciani
patent: 6743826 (2004-06-01), Hegedus et al.
patent: 6749868 (2004-06-01), Desai et al.
patent: 6753006 (2004-06-01), Desai et al.
patent: 6759431 (2004-07-01), Hunter et al.
patent: 7119124 (2006-10-01), Hegedus et al.
patent: 7332568 (2008-02-01), Trieu et al.
patent: 2003/0185894 (2003-10-01), Zenoni et al.
patent: 2003/0187062 (2003-10-01), Zenoni et al.
patent: 2003/0199425 (2003-10-01), Desai et al.
patent: 2005/0004002 (2005-01-01), Desai et al.
patent: 2005/0009731 (2005-01-01), Desai et al.
patent: 2005/0064028 (2005-03-01), Hegedus et al.
patent: 2006/0073175 (2006-04-01), Soon-Shiong et al.
patent: 2006/0083782 (2006-04-01), Desai et al.
patent: 2006/0121119 (2006-06-01), Zenoni et al.
patent: 2006/0199248 (2006-09-01), Trieu et al.
patent: 2006/0257326 (2006-11-01), Desai et al.
patent: 2006/0263434 (2006-11-01), Desai et al.
patent: 2007/0020337 (2007-01-01), Zenoni et al.
patent: 2007/0082838 (2007-04-01), De et al.
patent: 2007/0087022 (2007-04-01), Desai et al.
patent: 2007/0092563 (2007-04-01), Desai et al.
patent: 2007/0093547 (2007-04-01), Desai et al.
patent: 2007/0116774 (2007-05-01), Desai et al.
patent: 2007/0117133 (2007-05-01), Trieu et al.
patent: 2007/0117744 (2007-05-01), Desai et al.
patent: 2007/0117862 (2007-05-01), Desai et al.
patent: 2007/0117863 (2007-05-01), Desai et al.
patent: 2007/0128290 (2007-06-01), Desai et al.
patent: 2007/0129448 (2007-06-01), Desai et al.
patent: 2007/0166388 (2007-07-01), Desai et al.
patent: 2009/0098210 (2009-04-01), Desai et al.
patent: 2009/0263483 (2009-10-01), Desai et al.
patent: 0 227 593 (1987-07-01), None
patent: 0 544 292 (1993-06-01), None
patent: 0 544 292 (1993-06-01), None
patent: 2 775 900 (1999-09-01), None
patent: 2127606 (1999-03-01), None
patent: WO 92/07259 (1992-04-01), None
patent: WO 94/13300 (1994-06-01), None
patent: WO 94/18954 (1994-09-01), None
patent: WO-94/20072 (1994-09-01), None
patent: WO-95/03036 (1995-02-01), None
patent: WO-96/40829 (1996-12-01), None
patent: WO 97/10850 (1997-03-01), None
patent: WO 98/07410 (1998-02-01), None
patent: WO 98/14174 (1998-04-01), None
patent: WO 98/14175 (1998-04-01), None
patent: WO 99/00113 (1999-01-01), None
patent: WO-99/13914 (1999-03-01), None
patent: WO 99/39696 (1999-08-01), None
patent: WO 00/06152 (2000-02-01), None
patent: WO 00/23117 (2000-04-01), None
patent: WO-00/64437 (2000-11-01), None
patent: WO 00/71079 (2000-11-01), None
patent: WO 01/89522 (2001-11-01), None
patent: WO 02/087545 (2002-11-01), None
patent: WO 03/096944 (2003-11-01), None
patent: WO 2004/007520 (2004-01-01), None
patent: WO 2004/052401 (2004-06-01), None
patent: WO 2004/052401 (2004-06-01), None
patent: WO 2006/034147 (2005-03-01), None
patent: WO 2006/034147 (2005-03-01), None
patent: WO 2005/117952 (2005-12-01), None
patent: WO 2005/117952 (2005-12-01), None
Damascelli, B., et al. 2001 Cancer 92(10): 2592-2602.
Ibrahim, N., et al. 2000 Proc Am Soc Clinc Oncol 19: abstract 609F (2 pages).
Altmayer, P. et al. (1995). “Propofol Binding to Human Blood Proteins,”Arzneimittel Forschung Drug Research45(II)(10):1053-1056.
Calabresi, P. et al. (1996). Introduction of “Chemotherapy of Neoplastic Disease,” Section X inThe Pharmacological Basis of Therapeutics, 9thed., McGraw-Hill: New York, pp. 1225-1230.
Carter, D.C. et al. (1994). “Structures of Serum Albumin,”Advances in Protein Chemistry. Schumaker, V.N., ed., Academic Press, Inc.: San Diego, CA, 45:153-203.
Chuang, V. T. G. et al. (May 2002). “Pharmaceutical Strategies Utilizing Recombinant Human Serum Albumin,”Pharmaceutical Research19(5):569-577.
Curry et al. (1998). “Crystal Structure of Human Serum Albumin Complexed with Fatty Acid Reveals an Asymmetric Distribution of Binding Sites,”Nature Structural Biology5(9):827-835.
Curry, S. et al. (Nov. 23, 1999). “Fatty Acid Binding to Human Serum Albumin: New Insights From Crystallographic Studies,”Biochim. Biophys. Acta1441(2-3):131-140.
Fehske, K. J. et al. (Jan. 1, 1981). “The Location of Drug Binding Sites in Human Serum Albumin,”Biochemical Pharmacology30(1):687-692.
Finlayson, J.S. (1980). “Albumin Products,”Seminars in Thrombosis and Hemostasis6(2):85-120.
Garrido, M.J. et al. (1994). “Caracterización de la Fijación de Propofol a las Proteínas Plasmáticas y Posibles Interacciones,”Rev. Esp. Anestesiol. Reanim. 41(6):308-312. (English abstract only, one page.).
Halliwell, B. (1989). “Protection Against Tissue Damage in Vivo by Desferrioxamine: What is Its Mechanism of Action?”Free Radic. Biol. Med. 7(6):645-651.
Hauser, C.J. et al. (Jun. 1980). “Oxygen Transport Responses to Colloids and Crystalloids in Critically Ill Surgical Patients,”Surgery, Gynecology and Obstetrics150(6):811-816.
He, X.M. et al. (Jul. 16, 1992). “Atomic Structure and Chemistry of Human Serum Albumin,”Nature358(6383):209-215.
International Search Report mailed Nov. 3

Affiliated with

Also associated with

Rating

Compositions and methods of delivery of pharmacological agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods of delivery of pharmacological agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods of delivery of pharmacological agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4204074